ngTMA and Lunaphore!

Lunaphore Technologies S.A. and the Translational Research Unit (TRU) of the Institute of Pathology at University of Bern have received a grant from the impulse program Swiss Innovation Power promoted by Innosuisse, the Swiss Innovation Agency, to pursue a research collaboration. The project aims to study isolated cancer cell clusters, called tumor buds (TB), in colorectal cancer (CRC), using Lunaphore's high-multiplexed immunostaining technology COMET™, to expand our understanding of tumor budding events and improve cancer prognosis as well as personalized medicine.

More info: https://bit.ly/3BWVgCG